{
    "nctId": "NCT00898898",
    "briefTitle": "Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831",
    "officialTitle": "Analyses of c-Myc (MYC) and Topoisomerase II Alpha (TOP2A) Copy Number Aberrations; MYC, Insulin-like Growth Factor Receptor-1 (IGF-1R) and PTEN Protein Expressions; and Phosphatidylinositol 3' Kinase (PIK3) Gene Mutations in N9831 Primary Breast Tumors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2837,
    "primaryOutcomeMeasure": "Levels of primary breast tumor protein expression of MYC, IGF-1R, and PTEN assessed using standard immunohistochemical (IHC) procedures",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Diagnosed with breast cancer and treated on clinical trial NCCTG-N9831\n\n  \\* Randomized to treatment\n* HER-2 positive disease\n* Whole tissue blocks and/or tissue microarray sections available\n* Hormone receptor status:\n\n  \\* ER/PR status known\n* Any menopausal status",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}